CLINICAL_TRIALS
trial_result
· 2014-02-25
Clinical Trial Update: Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis [Phase 3]
Summary
Phase 3 clinical trial update for certolizumab pegol in adult-onset active and progressive psoriatic arthritis has completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB BIOSCIENCES GmbH | Conditions: Arthritis, Psoriatic | Phase 3 | Status: COMPLETED | Results posted: 2014-02-25